Editorial Comment

You have free access to this content

Postural orthostatic tachycardia syndrome as a clinically important subgroup of chronic fatigue syndrome: further evidence for central nervous system dysfunctioning

  1. J. Nijs1,2,
  2. K. Ickmans1,2

Article first published online: 8 FEB 2013

DOI: 10.1111/joim.12034

Issue

Journal of Internal Medicine

Journal of Internal Medicine

Volume 273, Issue 5, pages 498–500, May 2013

Additional Information

How to Cite

Nijs, J. and Ickmans, K. (2013), Postural orthostatic tachycardia syndrome as a clinically important subgroup of chronic fatigue syndrome: further evidence for central nervous system dysfunctioning. Journal of Internal Medicine, 273: 498–500. doi: 10.1111/joim.12034

Author Information

  1. 1

    Pain in Motion Research Group, Departments of Human Physiology and Rehabilitation Sciences, Faculty of Physical Education & Physiotherapy, Vrije Universiteit Brussel, Belgium

  2. 2

    Department of Physical Medicine and Physiotherapy, University Hospital Brussels, Belgium

* Correspondence: Jo Nijs, Vrije Universiteit Brussel, Building L-Mfys, Pleinlaan 2, BE-1050 Brussels, Belgium.
(fax: +3226292876; e-mail: Jo.Nijs@vub.ac.be).

  1. This article is linked to: The Original Article by Lewis et al., Clinical characteristics of a novel subgroup of chronic fatigue syndrome patients with postural orthostatic tachycardia syndrome. 273, 5, 501-510, Article first published online: 7 JAN 2013.

Publication History

  1. Issue published online: 22 APR 2013
  2. Article first published online: 8 FEB 2013
  3. Accepted manuscript online: 19 JAN 2013 12:00PM EST

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (96K)

References

  • 1
    Lewis L, Pairman J, Spickett G, Newton J. Clinical characteristics of a novel subgroup of chronic fatigue syndrome patients with postural orthostatic tachycardia syndrome. J Intern Med 2013; in press.
  • 2
    Hoad A, Spickett G, Elliott J, Newton J. Postural orthostatic tachycardia syndrome is an under-recognised condition in chronic fatigue syndrome. Q J Med 2008; 101: 961–5.
  • 3
    Schondorf R, Benoit J, Wein T et al. Orthostatic intolerance in the chronic fatigue syndrome. J Auton Nerv Syst 1999; 75: 192–201.
  • 4
    Breimhorst M, Hondrich M, Rebhorn C, May A, Birklein F. Sensory and sympathetic correlates of heat pain sensitization and habituation in men and women. Eur J Pain 2012; 16: 1281–92.
    Direct Link:
  • 5
    Carruthers B, Jain A, De Meirleir K et al. Myalgic encephalomyelitis/chronic fatigue syndrome: clinical working case definition, diagnostic and treatment protocols. J Chronic Fatigue Syndr 2003; 11: 7–115.
  • 6
    Parsaik A, Allison TG, Singer W et al. Deconditioning in patients with orthostatic intolerance. Neurology. 2012; 79: 1435–9.
  • 7
    Ocon AJ, Messer ZR, Medow MS, Stewart JM. Increasing orthostatic stress impairs neurocognitive functioning in chronic fatigue syndrome with postural tachycardia syndrome. Clin Sci (Lond). 2012; 122: 227–38.
  • 8
    Sutcliffe K, Gray J, Tan MP et al. Home orthostatic training in chronic fatigue syndrome–a randomized, placebo-controlled feasibility study. Eur J Clin Invest 2010; 40: 18–24.
    Direct Link:
  • 9
    Ocon AJ, Medow MS, Taneja I, Clarke D, Stewart JM. Decreased upright cerebral blood flow and cerebral autoregulation in normocapnic postural tachycardia syndrome. Am J Physiol Heart Circ Physiol. 2009; 297: H664–73.
  • 10
    Biswal B, Kunwar P, Natelson BH. Cerebral blood flow is reduced in chronic fatigue syndrome as assessed by arterial spin labeling. J Neurol Sci 2011; 301: 9–11.
  • 11
    Stewart JM, Medow MS, Messer ZR, Baugham IL, Terilli C, Ocon AJ. Postural neurocognitive and neuronal activated cerebral blood flow deficits in young chronic fatigue syndrome patients with postural tachycardia syndrome. Am J Physiol Heart Circ Physiol. 2012; 302: H1185–94.
  • 12
    Khan F, Kennedy G, Spence VA, Newton DJ, Belch JJ. Peripheral cholinergic function in humans with chronic fatigue syndrome, Gulf War syndrome and with illness following organophosphate exposure. Clin Sci (Lond) 2004; 106: 183–9.
  • 13
    Allen J, Murray A, Di Maria C, Newton JL. Chronic fatigue syndrome and impaired peripheral pulse characteristics on orthostasis–a new potential diagnostic biomarker. Physiol Meas 2012; 33: 231–41.
  • 14
    Jones DE, Hollingsworth KG, Taylor R, Blamire AM, Newton JL. Abnormalities in pH handling by peripheral muscle and potential regulation by the autonomic nervous system in chronic fatigue syndrome. J Intern Med 2010; 267: 394–401.
    Direct Link:
  • 15
    Newton JL, Sheth A, Shin J et al. Lower ambulatory blood pressure in chronic fatigue syndrome. Psychosom Med 2009; 71: 361–5.
  • 16
    Whiteside A, Hansen S, Chaudhuri A. Exercise lowers pain threshold in chronic fatigue syndrome. Pain 2004; 109: 497–9.
  • 17
    Meeus M, Roussel NA, Truijen S, Nijs J. Reduced pressure pain thresholds in response to exercise in chronic fatigue syndrome but not in chronic low back pain: an experimental study. J Rehabil Med 2010; 42: 884–90.
  • 18
    Van Oosterwijck J, Nijs J, Meeus M et al. Pain inhibition and postexertional malaise in myalgic encephalomyelitis/chronic fatigue syndrome: an experimental study. J Intern Med 2010; 268: 265–78.
    Direct Link:
  • 19
    Nijs J, Kosek E, van Oosterwijck J, Meeus M. Dysfunctional endogenous analgesia during exercise in patients with chronic pain: To exercise or not to exercise? Pain Physician 2012; 15: ES205–13.
  • 20
    Neary JP, Roberts ADW, Leavins N, Harrison MF, Croll JC, Sexsmith JR. Prefrontal cortex oxygenation during incremental exercise in chronic fatigue syndrome. Clin Physiol Funct Imaging 2008; 28: 364–72.
    Direct Link:
  • 21
    Nijs J, Meeus M, Van Oosterwijck J et al. In the mind or in the brain? Scientific evidence for central sensitization in chronic fatigue syndrome. Eur J Clin Invest 2012; 42: 203–12.
    Direct Link:
  • 22
    Puri BK, Jakeman PM, Agour M et al. Regional grey and white matter volumetric changes in myalgic encephalomyelitis (chronic fatigue syndrome): a voxel-based morphometry 3 T MRI study. Br J Radiol 2012; 85: e270–3.
  • 23
    de Lange FP, Kalkman JS, Bleijenberg G, Hagoort P, van der Meer JW, Toni I. Gray matter volume reduction in the chronic fatigue syndrome. Neuroimage. 2005; 26: 777–81.
  • 24
    Barnden LR, Crouch B, Kwiatek R et al. A brain MRI study of chronic fatigue syndrome: evidence of brainstem dysfunction and altered homeostasis. NMR Biomed 2011; 24: 1302–12.
    Direct Link:
  • 25
    Costa DC, Tannock C, Brostoff J. Brainstem perfusion is impaired in chronic fatigue syndrome. QJM 1995; 88: 767–73.
  • 26
    Tirelli U, Chierichetti F, Tavio M et al. Brain positron emission tomography (PET) in chronic fatigue syndrome: preliminary data. Am J Med 1998; 105: 54S–8S.
  • 27
    Yamamoto S, Ouchi Y, Onoe H et al. Reduction of serotonin transporters of patients with chronic fatigue syndrome. NeuroReport 2004; 15: 2571–4.
  • 28
    Cleare AJ. The HPA axis and the genesis of chronic fatigue syndrome. Trends Endocrinol Metab 2004; 15: 55–63.
  • 29
    Van Den Eede F, Moorkens G, Van Houdenhove B, Cosyns P, Claes SJ. Hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome. Neuropsychobiol 2007; 55: 112–20.
View Full Article (HTML) Get PDF (96K)